The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(trifluoromethoxy)benzyl)pyrrolidine-3-carboxamide ID: ALA1090400
PubChem CID: 46884037
Max Phase: Preclinical
Molecular Formula: C13H15F3N2O2
Molecular Weight: 288.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccc(OC(F)(F)F)cc1)C1CCNC1
Standard InChI: InChI=1S/C13H15F3N2O2/c14-13(15,16)20-11-3-1-9(2-4-11)7-18-12(19)10-5-6-17-8-10/h1-4,10,17H,5-8H2,(H,18,19)
Standard InChI Key: VDOIMCXMWAWTPV-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
5.5277 -3.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5266 -4.0523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2414 -4.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9578 -4.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9550 -3.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2396 -2.8122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8132 -2.8126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0988 -3.2253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3842 -2.8130 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.0990 -4.0503 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.8851 -2.4285 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.6730 -4.4632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3868 -4.0496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1019 -4.4610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8159 -4.0468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1032 -5.2860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6062 -4.2710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0669 -3.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5583 -2.9369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7834 -3.2199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 10 1 0
2 3 1 0
8 11 1 0
5 6 2 0
4 12 1 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 1 0
1 7 1 0
15 14 1 0
3 4 2 0
14 16 2 0
15 17 1 0
7 8 1 0
8 9 1 0
4 5 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 15 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 288.27Molecular Weight (Monoisotopic): 288.1086AlogP: 1.81#Rotatable Bonds: 4Polar Surface Area: 50.36Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.50CX LogP: 2.16CX LogD: -0.70Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.89Np Likeness Score: -1.29
References 1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB.. (2010) Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity., 20 (7): [PMID:20202843 ] [10.1016/j.bmcl.2010.01.107 ]